MiMedx Group, Inc (MDXG) earnings
MDXG earnings moved a median of +1.22% by the close. Quarterly and annual MDXG reports and results, each read against the price at its own news timestamp. Back to the MDXG overview →
30 measured MDXG earnings events.
Where these MDXG earnings landedvs 30 measured MDXG earnings reactions
| Middle 50% of MDXG earnings reactions | -3.15% to +8.89% |
|---|---|
| Median reaction (to close) | +1.22% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 MDXG earnings events with a measured close landed between -3.15% and +8.89%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026 | Press release | +0.10% | -1.68% | |
| Form 10-Q MIMEDX GROUP, INC. For: Jun 30 | SEC filing · Form 10-Q | -1.92% | +9.49% | |
| MIMEDX Announces Second Quarter 2026 Operating & Financial Results | Press release | -1.92% | +9.49% | |
| MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29 | Press release | +0.70% | +0.70% | |
| Form 10-Q MIMEDX GROUP, INC. For: Mar 31 | SEC filing · Form 10-Q | +9.51% | +10.16% | |
| MIMEDX Announces First Quarter 2026 Operating & Financial Results | Press release | +9.51% | +10.16% | |
| MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29 | Press release | +1.56% | +3.12% | |
| Form 10-K MIMEDX GROUP, INC. For: Dec 31 | SEC filing · Form 10-K | +0.48% | -5.72% | |
| Form 10-Q MIMEDX GROUP, INC. For: Sep 30 | SEC filing · Form 10-Q | -2.60% | -3.65% | |
| MIMEDX Announces Record Revenue for Third Quarter 2025 | Press release | -2.60% | -3.65% | |
| MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29 | Press release | +1.89% | +1.51% | |
| Form 10-Q MIMEDX GROUP, INC. For: Jun 30 | SEC filing · Form 10-Q | -2.63% | -5.39% | |
| MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results | Press release | -2.63% | -5.39% | |
| MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30 | Press release | +0.79% | +6.00% | |
| Form 10-Q MIMEDX GROUP, INC. For: Mar 31 | SEC filing · Form 10-Q | -1.53% | -4.24% | |
| MIMEDX Announces First Quarter 2025 Operating and Financial Results | Press release | -1.53% | -4.24% | |
| MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30 | Press release | -0.07% | -1.34% | |
| Form 10-K MIMEDX GROUP, INC. For: Dec 31 | SEC filing · Form 10-K | +2.63% | +7.11% | |
| Form 10-Q MIMEDX GROUP, INC. For: Sep 30 | SEC filing · Form 10-Q | +10.06% | +10.13% | |
| MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Press release | +10.06% | +10.13% | |
| MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 | Press release | -0.70% | +0.17% | |
| Form 10-Q MIMEDX GROUP, INC. For: Jun 30 | SEC filing · Form 10-Q | +1.23% | +2.77% | |
| MIMEDX Announces Second Quarter 2024 Operating and Financial Results | Press release | +1.23% | +2.77% | |
| MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31 | Press release | +0.68% | +1.36% | |
| Form 10-Q MIMEDX GROUP, INC. For: Mar 31 | SEC filing · Form 10-Q | +2.86% | +13.16% | |
| MIMEDX Announces First Quarter 2024 Operating and Financial Results | Press release | +2.86% | +13.16% | |
| MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30 | Press release | -1.58% | -1.27% | |
| Form 10-K MIMEDX GROUP, INC. For: Dec 31 | SEC filing · Form 10-K | -0.11% | -9.33% | |
| Form 10-Q MIMEDX GROUP, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.08% | |
| MIMEDX Announces Third Quarter 2023 Operating and Financial Results | Press release | +0.00% | +1.08% |
Keep exploring
More MDXG: analyst actions → · SEC filings → · MDXG overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | 265 | +0.27% | 52% |
| EVOTEC AG S/ADR (EVTCY) | 265 | 0.00% | 17% |
| Relmada Therapeutics, Inc. (RLMD) | 265 | -0.01% | 44% |
| HUTCHMED (China) Limited - American Depositary Shares (HCM) | 263 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.